Exhibition Overview

Adding impetus to the innovative development of biopharmaceuticals - expanding and strengthening the bioeconomy

The 14th Five Year Plan and the 2035 Vision Outline propose to accelerate the development of industries such as biopharmaceuticals, biological breeding, biomaterials, and bioenergy, and to expand and strengthen the bioeconomy. The biopharmaceutical industry is a strategic emerging industry that is related to national economy, people's livelihood, and national security, covering multiple aspects such as the biotechnology industry, pharmaceutical industry, and biomedical engineering industry.

In recent years, guided by favorable policies, China's biopharmaceutical industry has entered a fast lane of development, with a series of new products and services providing new assistance to ensure people's lives and health. Looking at the industry, there has been a significant increase in R&D investment across the entire industry, with thousands of new drugs entering clinical trials and hundreds of new drugs conducting international multicenter clinical trials. The number of approved new drugs is increasing day by day. Looking at enterprises, traditional pharmaceutical enterprises are accelerating their transformation pace, constantly laying out innovative drug research and development, and a large number of emerging biotechnology companies are gradually established and growing rapidly. These innovative entities are important forces in promoting the innovative development of biopharmaceuticals, gathering industry experts and analyzing cutting-edge developments. As of the end of 2022, there are 4120 biopharmaceutical related enterprises in Xi'an High tech Zone, and the scale of the biopharmaceutical industry has exceeded 60 billion yuan, Ranked among the top national high-tech zones in the central and western regions. The China (Xi'an) Biomedical and Technical Equipment Exhibition, hosted by the Airport New City Management Committee of Xixian New Area in Shaanxi Province and organized by Zhongkai International Exhibition (Beijing) Co., Ltd., will be held at the Xi'an Airport Convention and Exhibition Center from April 25th to 27th, 2024. The exhibition will continue to adhere to the development concept of openness, innovation, cooperation, and win-win, continuously explore and break through the innovation of biopharmaceutical technology and industry, promote the development of the medical device industry, and create an innovative leader in China's biopharmaceutical industry. We will comprehensively integrate various forms of activities such as exhibition displays, annual innovative product selection and commendation, summit forums, new product releases, procurement conferences, training and exchanges, and strive to create a cutting-edge platform for showcasing and promoting the biopharmaceutical and related industries to the country and even the world.

Exhibition scope

◆Exhibition area for biopharmaceutical products and achievements:Fully showcase the latest products, research achievements, and application development in the field of biopharmaceuticals, and invite biopharmaceutical enterprises in protein drugs, antibody drugs, stem cell therapy, cell therapy, gene therapy products, as well as vaccine treatment and prevention;

◆Exhibition area for biopharmaceutical testing and diagnostic applications:Encourage enterprises and research institutions in gene diagnosis and testing, diagnostic reagents and other testing products, as well as diagnostic technology applications;

◆Exhibition area for biopharmaceutical research and development, analysis, and manufacturing equipment: Related enterprises and research institutions such as biopharmaceutical manufacturing equipment providers, biopharmaceutical research and development, analytical instrument equipment production, suppliers, etc

◆Exhibition area for biopharmaceutical research and manufacturing supply system:Supply enterprises of biopharmaceutical raw materials, active pharmaceutical ingredients, enzymes, additives, stabilizers, and other industrial chains;

◆Exhibition area for biopharmaceutical research and development, manufacturing technology services: CXO, intellectual property, information consulting, project evaluation, legal consulting, investment and other enterprises and research institutions participate in the exhibition.

◆Biomedical Industry Park and Development Policy Exhibition Area: Exhibiting in various biopharmaceutical industry parks, publishing policies and investment environments for the development of each park; Discuss the current situation and prospects of industrial development, etc;

◆Biomedical talent exchange exhibition area:Image display of international and listed companies in the biopharmaceutical industry, recruitment booths for human resources departments, and exhibition of achievements in various universities.

• Company:Zhongkai International (Beijing) Exhibition Co., Ltd
• Telephone:18510751672
• Truename:Manager Wu
• Mobile:18510751672
• E-mail:468430447@qq.com
• Address:15 Guangren West Road, Airport New City, Xixian New Area, Xianyang City, Shaanxi Province

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870